title: Sclerostin: More than a bone formation brake.
abstract: Anti-sclerostin treatment spurs an unexpected acceleration of bone erosion in a mouse model of rheumatoid arthritis (Wehmeyeret al, this issue).
authors.affiliation: Shriners Hospital for Children and McGill University, Montreal, Quebec H4A 0A9, Canada. frauch@shriners.mcgill.ca.
authors.forename: Frank
authors.initials: F
authors.lastname: Rauch
authors.affiliation: Department of Rheumatology, McMaster University, Hamilton, Ontario L8N 1Y2, Canada.
authors.forename: Rick
authors.initials: R
authors.lastname: Adachi
mesh_terms: D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000378:metabolism*; D001842:Bone and Bones / Q000378:metabolism; D002986:Clinical Trials as Topic; D005246:Feedback; D006801:Humans; D010012:Osteogenesis
chemical_list: D019485:Bone Morphogenetic Proteins